{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T13:46:15Z","timestamp":1772027175826,"version":"3.50.1"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Gastro"],"published-print":{"date-parts":[[2004,8]]},"DOI":"10.1007\/s11938-004-0017-1","type":"journal-article","created":{"date-parts":[[2007,6,3]],"date-time":"2007-06-03T19:14:32Z","timestamp":1180898072000},"page":"307-316","source":"Crossref","is-referenced-by-count":12,"title":["Dietary treatment of the irritable bowel syndrome"],"prefix":"10.1007","volume":"7","author":[{"given":"Peter","family":"Whorwell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Lea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"17_CR1","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1053\/gast.2002.37095","volume":"123","author":"DA Drossman","year":"2002","unstructured":"Drossman DA, Camilleri M, Mayer EA, Whitehead WE: AGA technical review on irritable bowel syndrome. Gastroenterology 2002, 123: 2108\u20132131.","journal-title":"Gastroenterology"},{"key":"17_CR2","doi-asserted-by":"crossref","first-page":"643","DOI":"10.2165\/00019053-200119060-00003","volume":"19","author":"R Lea","year":"2001","unstructured":"Lea R, Whorwell PJ: Quality of life in irritable bowel syndrome. Pharmacoeconomics 2001, 19: 643\u2013653.","journal-title":"Pharmacoeconomics"},{"key":"17_CR3","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1053\/gast.2002.33741","volume":"122","author":"KW Olden","year":"2002","unstructured":"Olden KW: Diagnosis of irritable bowel syndrome. Gastroenterology 2002, 122: 1701\u20131714.","journal-title":"Gastroenterology"},{"key":"17_CR4","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1053\/gast.2001.23417","volume":"120","author":"American Gastroenterological Association","year":"2001","unstructured":"American Gastroenterological Association: Medical position statement: guidelines for the evaluation of food allergies. Gastroenterology 2001, 120: 1023\u20131025. A comprehensive and up-to-date review of food allergies.","journal-title":"Gastroenterology"},{"key":"17_CR5","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1651-2227.1996.tb14242.x","volume":"412","author":"A Fasano","year":"1996","unstructured":"Fasano A: Where have all the American celiacs gone? Acta Paediatr Suppl 1996, 412: 20\u201324.","journal-title":"Acta Paediatr Suppl"},{"key":"17_CR6","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1016\/S0140-6736(01)06581-3","volume":"358","author":"DS Sanders","year":"2001","unstructured":"Sanders DS, Carter MJ, Hurlstone DP, et al.: Association of adult celiac disease with irritable bowel syndrome: a case-control study in patients fulfilling ROME II criteria referred to secondary care. Lancet 2001, 358: 1504\u20131508. This study suggested that routine testing, and if appropriate treatment, for celiac disease in IBS patients may be worthwhile.","journal-title":"Lancet"},{"key":"17_CR7","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1053\/gast.2001.29572","volume":"121","author":"U Wahnschaffe","year":"2001","unstructured":"Wahnschaffe U, Ullrich R, Riecken EO, Schulzke JD: Celiac disease-like abnormalities in a subgroup of patients with irritable bowel syndrome. Gastroenterology 2001, 121: 1329\u20131338.","journal-title":"Gastroenterology"},{"key":"17_CR8","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1046\/j.1365-2036.2003.01666.x","volume":"18","author":"B Shahbazkhani","year":"2003","unstructured":"Shahbazkhani B, Forootan M, Merat S, et al.: celiac disease presenting with symptoms of irritable bowel syndrome. Aliment Pharmacol Ther 2003, 18: 231\u2013235.","journal-title":"Aliment Pharmacol Ther"},{"key":"17_CR9","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/0016-5085(88)90319-8","volume":"95","author":"KB Klein","year":"1988","unstructured":"Klein KB: Controlled treatment trials in the irritable bowel syndrome: a critique. Gastroenterology 1988, 95: 232\u2013241.","journal-title":"Gastroenterology"},{"key":"17_CR10","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1046\/j.1365-2036.2001.00937.x","volume":"15","author":"T Poynard","year":"2001","unstructured":"Poynard T, Regimbeau C, Benhamou Y: Meta-analysis of smooth muscle relaxants in the treatment of irritable bowel syndrome. Aliment Pharmacol Ther 2001, 15: 355\u2013361.","journal-title":"Aliment Pharmacol Ther"},{"key":"17_CR11","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/0016-5085(91)90215-7","volume":"100","author":"E Guthrie","year":"1991","unstructured":"Guthrie E, Creed F, Dawson D, Tomenson B: A controlled trial of psychological treatment for the irritable bowel syndrome. Gastroenterology 1991, 100: 450\u2013457.","journal-title":"Gastroenterology"},{"key":"17_CR12","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0002-9343(99)00299-5","volume":"108","author":"JL Jackson","year":"2000","unstructured":"Jackson JL, O\u2019Malley PG, Tomkins G, et al.: Treatment of functional gastrointestinal disorders with antidepressant medications: a meta-analysis. Am J Med 2000, 108: 65\u201372.","journal-title":"Am J Med"},{"key":"17_CR13","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/S0140-6736(84)92793-4","volume":"2","author":"PJ Whorwell","year":"1984","unstructured":"Whorwell PJ, Prior A, Faragher EB: Controlled trial of hypnotherapy in the treatment of severe refractory irritable-bowel syndrome. Lancet 1984, 2: 1232\u20131234.","journal-title":"Lancet"},{"key":"17_CR14","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s11938-002-0052-8","volume":"5","author":"R Lea","year":"2002","unstructured":"Lea R, Whorwell PJ: Serotonergic agents in the treatment of functional gastrointestinal disorders. Curr Treat Options Gastroenterol 2002, 5: 293\u2013300.","journal-title":"Curr Treat Options Gastroenterol"},{"key":"17_CR15","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1111\/j.1572-0241.1999.01226.x","volume":"94","author":"R Dainese","year":"1999","unstructured":"Dainese R, Galliani EA, De Lazzari F, et al.: Discrepancies between reported food intolerance and sensitization test findings in irritable bowel syndrome patients. Am J Gastroenterol 1999, 94: 1892\u20131897.","journal-title":"Am J Gastroenterol"},{"key":"17_CR16","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/S0140-6736(94)90234-8","volume":"343","author":"E Young","year":"1994","unstructured":"Young E, Stoneham MD, Petruckevitch A, et al.: A population study of food intolerance. Lancet 1994, 343: 1127\u20131130.","journal-title":"Lancet"},{"key":"17_CR17","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1046\/j.1365-2982.2000.00221.x","volume":"12","author":"M O\u2019Sullivan","year":"2000","unstructured":"O\u2019Sullivan M, Clayton N, Breslin NP, et al.: Increased mast cells in the irritable bowel syndrome. Neurogastroenterol Motil 2000, 12: 449\u2013457.","journal-title":"Neurogastroenterol Motil"},{"key":"17_CR18","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1007\/BF01303164","volume":"38","author":"AP Weston","year":"1993","unstructured":"Weston AP, Biddle WL, Bhatia PS, Miner PB: Terminal ileal mucosal mast cells in irritable bowel syndrome. Dig Dis Sci 1993, 38: 1590\u20131595.","journal-title":"Dig Dis Sci"},{"key":"17_CR19","first-page":"538","volume":"54","author":"M Petitpierre","year":"1985","unstructured":"Petitpierre M, Gumowski P, Girard JP: Irritable bowel syndrome and hypersensitivity to food. Ann Allergy 1985, 54: 538\u2013540.","journal-title":"Ann Allergy"},{"key":"17_CR20","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/00005176-199007000-00015","volume":"11","author":"E Barau","year":"1990","unstructured":"Barau E, Dupont C: Modifications of intestinal permeability during food provocation procedures in pediatric irritable bowel syndrome. J Pediatr Gastroenterol Nutr 1990, 11: 72\u201377.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"17_CR21","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1053\/rmed.2001.1409","volume":"97","author":"A Roussos","year":"2003","unstructured":"Roussos A, Koursarakos P, Patsopoulos D, et al.: Increased prevalence of irritable bowel syndrome in patients with bronchial asthma. Respir Med 2003, 97: 75\u201379.","journal-title":"Respir Med"},{"key":"17_CR22","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1111\/j.1572-0241.1998.00531.x","volume":"93","author":"AM Niec","year":"1998","unstructured":"Niec AM, Frankum B, Talley NJ: Are adverse food reactions linked to irritable bowel syndrome? Am J Gastroenterol 1998, 93: 2184\u20132190.","journal-title":"Am J Gastroenterol"},{"key":"17_CR23","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1046\/j.1365-277X.2001.00284.x","volume":"14","author":"S Burden","year":"2001","unstructured":"Burden S: Dietary treatment of irritable bowel syndrome: current evidence and guidelines for future practice. J Hum Nutr Diet 2001, 14: 231\u2013241.","journal-title":"J Hum Nutr Diet"},{"key":"17_CR24","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0140-6736(82)92782-9","volume":"2","author":"VA Jones","year":"1982","unstructured":"Jones VA, McLaughlan P, Shorthouse M, et al.: Food intolerance: a major factor in the pathogenesis of irritable bowel syndrome. Lancet 1982, 2: 1115\u20131117.","journal-title":"Lancet"},{"key":"17_CR25","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0140-6736(83)90285-4","volume":"2","author":"SJ Bentley","year":"1983","unstructured":"Bentley SJ, Pearson DJ, Rix KJ: Food hypersensitivity in irritable bowel syndrome. Lancet 1983, 2: 295\u2013297.","journal-title":"Lancet"},{"key":"17_CR26","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1097\/00004836-198710000-00007","volume":"9","author":"AM McKee","year":"1987","unstructured":"McKee AM, Prior A, Whorwell PJ: Exclusion diets in irritable bowel syndrome: are they worthwhile? J Clin Gastroenterol 1987, 9: 526\u2013528.","journal-title":"J Clin Gastroenterol"},{"key":"17_CR27","doi-asserted-by":"crossref","unstructured":"Atkinson W, Sheldon T, Shaath N, Whorwell PJ: IgG antibodies to food: a role in irritable bowel syndrome. Gut 2004, in press.","DOI":"10.1136\/gut.2003.037697"},{"key":"17_CR28","first-page":"678","volume":"80","author":"NK Jain","year":"1985","unstructured":"Jain NK, Rosenberg DB, Ulahannan MJ, et al.: Sorbitol intolerance in adults. Am J Gastroenterol 1985, 80: 678\u2013681.","journal-title":"Am J Gastroenterol"},{"key":"17_CR29","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1093\/ajcn\/48.6.1424","volume":"48","author":"AS Truswell","year":"1988","unstructured":"Truswell AS, Seach JM, Thorburn AW: Incomplete absorption of pure fructose in healthy subjects and the facilitating effect of glucose. Am J Clin Nutr 1988, 48: 1424\u20131430.","journal-title":"Am J Clin Nutr"},{"key":"17_CR30","first-page":"2044","volume":"88","author":"F Fernandez-Banares","year":"1993","unstructured":"Fernandez-Banares F, Esteve-Pardo M, de Leon R, et al.: Sugar malabsorption in functional bowel disease: clinical implications. Am J Gastroenterol 1993, 88: 2044\u20132050.","journal-title":"Am J Gastroenterol"},{"key":"17_CR31","first-page":"583","volume":"2","author":"R Goldstein","year":"2000","unstructured":"Goldstein R, Braverman D, Stankiewicz H: Carbohydrate malabsorption and the effect of dietary restriction on symptoms of irritable bowel syndrome and functional bowel complaints. Isr Med Assoc J 2000, 2: 583\u2013587. This study suggested that combined carbohydrate intolerances were common in patients with IBS and that diets based on excluding these sugars may be worthwhile.","journal-title":"Isr Med Assoc J"},{"key":"17_CR32","doi-asserted-by":"crossref","first-page":"940","DOI":"10.3109\/00365529209000167","volume":"27","author":"P Symons","year":"1992","unstructured":"Symons P, Jones MP, Kellow JE: Symptom provocation in irritable bowel syndrome: effects of differing doses of fructose-sorbitol. Scand J Gastroenterol 1992, 27: 940\u2013944.","journal-title":"Scand J Gastroenterol"},{"key":"17_CR33","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/0016-5085(90)90621-7","volume":"99","author":"GF Nelis","year":"1990","unstructured":"Nelis GF, Vermeeren MA, Jansen W: Role of fructosesorbitol malabsorption in the irritable bowel syndrome. Gastroenterology 1990, 99: 1016\u20131020.","journal-title":"Gastroenterology"},{"key":"17_CR34","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1159\/000072061","volume":"67","author":"M Dapoigny","year":"2003","unstructured":"DapoignyM, Stockbrugger RW, Azpiroz F, et al.: Role of alimentation in irritable bowel syndrome. Digestion 2003, 67: 225\u2013233. A useful consensus report regarding the role of food intolerances in patients with IBS.","journal-title":"Digestion"},{"key":"17_CR35","first-page":"89","volume":"92","author":"TM Kajs","year":"1997","unstructured":"Kajs TM, Fitzgerald JA, Buckner RY, et al.: Influence of a methanogenic flora on the breath H2 and symptom response to ingestion of sorbitol or oat fiber. Am J Gastroenterol 1997, 92: 89\u201394.","journal-title":"Am J Gastroenterol"},{"key":"17_CR36","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1136\/gut.48.1.14","volume":"48","author":"J Serra","year":"2001","unstructured":"Serra J, Azpiroz F, Malagelada JR: Impaired transit and tolerance of intestinal gas in the irritable bowel syndrome. Gut 2001, 48: 14\u201319.","journal-title":"Gut"},{"issue":"1","key":"17_CR37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM199507063330101","volume":"333","author":"FL Suarez","year":"1995","unstructured":"Suarez FL, Savaiano DA, Levitt MD: A comparison of symptoms after the consumption of milk or lactosehydrolyzed milk by people with self-reported severe lactose intolerance. N Engl J Med 1995, 333(1):1\u20134.","journal-title":"N Engl J Med"},{"key":"17_CR38","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/j.1365-2036.1995.tb00427.x","volume":"9","author":"FL Suarez","year":"1995","unstructured":"Suarez FL, Savaiano DA, Levitt MD: Review article: the treatment of lactose intolerance. Aliment Pharmacol Ther 1995, 9: 589\u2013597.","journal-title":"Aliment Pharmacol Ther"},{"key":"17_CR39","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/S0899-9007(97)00435-8","volume":"14","author":"MJ Lewis","year":"1998","unstructured":"Lewis MJ, Whorwell PJ: Bran: may irritate irritable bowel. Nutrition 1998, 14: 470\u2013471.","journal-title":"Nutrition"},{"key":"17_CR40","first-page":"151","volume":"37","author":"KW Heaton","year":"1983","unstructured":"Heaton KW: Dietary fiber in perspective. Hum Nutr Clin Nutr 1983, 37: 151\u2013170.","journal-title":"Hum Nutr Clin Nutr"},{"key":"17_CR41","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1016\/S0140-6736(72)92974-1","volume":"2","author":"DP Burkitt","year":"1972","unstructured":"Burkitt DP, Walker AR, Painter NS: Effect of dietary fiber on stools and the transit-times and its role in the causation of disease. Lancet 1972, 2: 1408\u20131412.","journal-title":"Lancet"},{"key":"17_CR42","doi-asserted-by":"crossref","first-page":"295","DOI":"10.3109\/00365528509091653","volume":"20","author":"S Arffmann","year":"1985","unstructured":"Arffmann S, Andersen JR, Hegnhoj J, et al.: The effect of coarse wheat bran in the irritable bowel syndrome: a double-blind, cross-over study. Scand J Gastroenterol 1985, 20: 295\u2013298.","journal-title":"Scand J Gastroenterol"},{"key":"17_CR43","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1136\/gut.25.2.168","volume":"25","author":"PA Cann","year":"1984","unstructured":"Cann PA, Read NW, Holdsworth CD: What is the benefit of coarse wheat bran in patients with irritable bowel syndrome? Gut 1984, 25: 168\u2013173.","journal-title":"Gut"},{"key":"17_CR44","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/0016-5085(90)91292-E","volume":"98","author":"IJ Cook","year":"1990","unstructured":"Cook IJ, Irvine EJ, Campbell D, et al.: Effect of dietary fiber on symptoms and rectosigmoid motility in patients with irritable bowel syndrome: a controlled, crossover study. Gastroenterology 1990, 98: 66\u201372.","journal-title":"Gastroenterology"},{"key":"17_CR45","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0022-3999(92)90026-X","volume":"36","author":"S Fowlie","year":"1992","unstructured":"Fowlie S, Eastwood MA, Prescott R: Irritable bowel syndrome: assessment of psychological disturbance and its influence on the response to fiber supplementation. J Psychosom Res 1992, 36: 175\u2013180.","journal-title":"J Psychosom Res"},{"key":"17_CR46","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1159\/000199329","volume":"34","author":"W Kruis","year":"1986","unstructured":"Kruis W, Weinzierl M, Schussler P, Holl J: Comparison of the therapeutic effect of wheat bran, mebeverine, and placebo in patients with the irritable bowel syndrome. Digestion 1986, 34: 196\u2013201.","journal-title":"Digestion"},{"key":"17_CR47","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1136\/gut.28.2.221","volume":"28","author":"MR Lucey","year":"1987","unstructured":"Lucey MR, Clark ML, Lowndes J, Dawson AM: Is bran efficacious in irritable bowel syndrome? A doubleblind, placebo-controlled, crossover study. Gut 1987, 28: 221\u2013225.","journal-title":"Gut"},{"key":"17_CR48","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0140-6736(77)90605-5","volume":"2","author":"AP Manning","year":"1977","unstructured":"Manning AP, Heaton KW, Harvey RF: Wheat fiber and irritable bowel syndrome: a controlled trial. Lancet 1977, 2: 417\u2013418.","journal-title":"Lancet"},{"key":"17_CR49","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/j.1365-2036.1994.tb00323.x","volume":"8","author":"J Snook","year":"1994","unstructured":"Snook J, Shepherd HA: Bran supplementation in the treatment of irritable bowel syndrome. Aliment Pharmacol Ther 1994, 8: 511\u2013514.","journal-title":"Aliment Pharmacol Ther"},{"key":"17_CR50","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/S0140-6736(76)91402-1","volume":"1","author":"J Soltoft","year":"1976","unstructured":"Soltoft J, Krag B, Gudmand-Hoyer E, et al.: A doubleblind trial of the effect of wheat bran on symptoms of irritable bowel syndrome. Lancet 1976, 1: 270\u2013272.","journal-title":"Lancet"},{"key":"17_CR51","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0140-6736(94)91055-3","volume":"344","author":"CY Francis","year":"1994","unstructured":"Francis CY, Whorwell PJ: Bran and irritable bowel syndrome: time for reappraisal. Lancet 1994, 344: 39\u201340.","journal-title":"Lancet"},{"key":"17_CR52","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1023\/A:1016419906546","volume":"47","author":"GC Parisi","year":"2002","unstructured":"Parisi GC, Zilli M, Miani MP, et al.: High-fiber diet supplementation in patients with irritable bowel syndrome (IBS): a multicenter, randomized, open trial comparison between wheat bran diet and partially hydrolyzed guar gum (PHGG). Dig Dis Sci 2002, 47: 1697\u20131704.","journal-title":"Dig Dis Sci"},{"key":"17_CR53","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1136\/bmj.299.6708.1138","volume":"299","author":"DG Maxton","year":"1989","unstructured":"Maxton DG, Morris JA, Whorwell PJ: Ranking of symptoms by patients with the irritable bowel syndrome. BMJ 1989, 299: 1138.","journal-title":"BMJ"},{"key":"17_CR54","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1053\/gast.2002.35394","volume":"123","author":"J Serra","year":"2002","unstructured":"Serra J, Salvioli B, Azpiroz F, Malagelada JR: Lipidinduced intestinal gas retention in irritable bowel syndrome. Gastroenterology 2002, 123: 700\u2013706.","journal-title":"Gastroenterology"},{"key":"17_CR55","doi-asserted-by":"crossref","first-page":"422","DOI":"10.7326\/0003-4819-124-4-199602150-00006","volume":"124","author":"MD Levitt","year":"1996","unstructured":"Levitt MD, Furne J, Olsson S: The relation of passage of gas an abdominal bloating to colonic gas production. Ann Intern Med 1996, 124: 422\u2013424.","journal-title":"Ann Intern Med"},{"key":"17_CR56","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1056\/NEJM197509112931103","volume":"293","author":"RB Lasser","year":"1975","unstructured":"Lasser RB, Bond JH, Levitt MD: The role of intestinal gas in functional abdominal pain. N Engl J Med 1975, 293: 524\u2013526.","journal-title":"N Engl J Med"},{"key":"17_CR57","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1749-6632.1968.tb19031.x","volume":"150","author":"FR Steggerda","year":"1968","unstructured":"Steggerda FR: Gastrointestinal gas following food consumption. Ann N Y Acad Sci 1968, 150: 57\u201366.","journal-title":"Ann N Y Acad Sci"},{"key":"17_CR58","first-page":"441","volume":"39","author":"TG Ganiats","year":"1994","unstructured":"Ganiats TG, Norcross WA, Halverson AL, et al.: Does Beano prevent gas? A double-blind crossover study of oral alpha-galactosidase to treat dietary oligosaccharide intolerance. J Fam Pract 1994, 39: 441\u2013445.","journal-title":"J Fam Pract"},{"issue":"suppl 1","key":"17_CR59","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1079\/BJN2002631","volume":"88","author":"JA Madden","year":"2002","unstructured":"Madden JA, Hunter JO: A review of the role of the gut microflora in irritable bowel syndrome and the effects of probiotics. Br J Nutr 2002, 88(suppl 1):S67-S72.","journal-title":"Br J Nutr"},{"key":"17_CR60","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1111\/j.1572-0241.2000.02015.x","volume":"95","author":"S Nobaek","year":"2000","unstructured":"Nobaek S, Johansson ML, Molin G, et al.: Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome. Am J Gastroenterol 2000, 95: 1231\u20131238.","journal-title":"Am J Gastroenterol"},{"key":"17_CR61","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1023\/A:1020597001460","volume":"47","author":"S Sen","year":"2002","unstructured":"Sen S, Mullan MM, Parker TJ, et al.: Effect of Lactobacillus plantarum 299v on colonic fermentation and symptoms of irritable bowel syndrome. Dig Dis Sci 2002, 47: 2615\u20132620.","journal-title":"Dig Dis Sci"},{"key":"17_CR62","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1046\/j.1365-2036.2003.01543.x","volume":"17","author":"HJ Kim","year":"2003","unstructured":"Kim HJ, Camilleri M, McKinzie S, et al.: A randomized, controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther 2003, 17: 895\u2013904.","journal-title":"Aliment Pharmacol Ther"},{"key":"17_CR63","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1111\/j.1572-0241.2000.03368.x","volume":"95","author":"M Pimentel","year":"2000","unstructured":"Pimentel M, Chow EJ, Lin HC: Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome. Am J Gastroenterol 2000, 95: 3503\u20133506.","journal-title":"Am J Gastroenterol"},{"key":"17_CR64","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/j.1572-0241.2003.07946.x","volume":"98","author":"M Pimentel","year":"2003","unstructured":"Pimentel M, Chow EJ, Lin HC: Normalization of lactulose breath testing correlates with symptom improvement in irritable bowel syndrome: a double-blind, randomized, placebo-controlled study. Am J Gastroenterol 2003, 98: 412\u2013419.","journal-title":"Am J Gastroenterol"},{"key":"17_CR65","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1046\/j.1365-2036.2000.00808.x","volume":"14","author":"M Stefano Di","year":"2000","unstructured":"Di Stefano M, Strocchi A, Malservisi S, et al.: Nonabsorbable antibiotics for managing intestinal gas production and gas-related symptoms. Aliment Pharmacol Ther 2000, 14: 1001\u20131008.","journal-title":"Aliment Pharmacol Ther"},{"key":"17_CR66","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/00042737-199801000-00011","volume":"10","author":"MA Mendall","year":"1998","unstructured":"Mendall MA, Kumar D: Antibiotic use, childhood affluence, and irritable bowel syndrome (IBS). Eur J Gastroenterol Hepatol 1998, 10: 59\u201362.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"17_CR67","first-page":"55","volume":"87","author":"GF Stefanini","year":"1992","unstructured":"Stefanini GF, Prati E, Albini MC, et al.: Oral disodium cromoglycate treatment on irritable bowel syndrome: an open study on 101 subjects with diarrheic type. Am J Gastroenterol 1992, 87: 55\u201357.","journal-title":"Am J Gastroenterol"},{"key":"17_CR68","doi-asserted-by":"crossref","first-page":"535","DOI":"10.3109\/00365529509089786","volume":"30","author":"GF Stefanini","year":"1995","unstructured":"Stefanini GF, Saggioro A, Alvisi V, et al.: Oral cromolyn sodium in comparison with elimination diet in the irritable bowel syndrome, diarrheic type: multicenter study of 428 patients. Scand J Gastroenterol 1995, 30: 535\u2013541.","journal-title":"Scand J Gastroenterol"},{"key":"17_CR69","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/j.1365-2222.1991.tb00848.x","volume":"21","author":"C Lunardi","year":"1991","unstructured":"Lunardi C, Bambara LM, Biasi D, et al.: Double-blind, cross-over trial of oral sodium cromoglycate in patients with irritable bowel syndrome due to food intolerance. Clin Exp Allergy 1991, 21: 569\u2013572.","journal-title":"Clin Exp Allergy"},{"key":"17_CR70","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1002\/pds.836","volume":"12","author":"C Huerta","year":"2003","unstructured":"Huerta C, Garcia Rodriguez LA, Wallander MA, Johansson S: Users of oral steroids are at a reduced risk of developing irritable bowel syndrome. Pharmacoepidemiol Drug Saf 2003, 12: 583\u2013588.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"17_CR71","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1046\/j.1365-2036.2003.01640.x","volume":"18","author":"SP Dunlop","year":"2003","unstructured":"Dunlop SP, Jenkins D, Neal KR, et al.: Randomized, double-blind, placebo-controlled trial of prednisolone in post-infectious irritable bowel syndrome. Aliment Pharmacol Ther 2003, 18: 77\u201384.","journal-title":"Aliment Pharmacol Ther"},{"key":"17_CR72","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/00042737-199802000-00003","volume":"10","author":"S Rao","year":"1998","unstructured":"Rao S, Welcher KZ, Stumbo P: Is coffee a colonic stimulant? Eur J Gastroenterol Hepatol 1998, 10: 113\u2013118.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"17_CR73","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/0016-5085(78)90865-X","volume":"75","author":"LA Turnberg","year":"1978","unstructured":"Turnberg LA: Coffee and the gastrointestinal tract. Gastroenterology 1978, 75: 529\u2013530.","journal-title":"Gastroenterology"},{"key":"17_CR74","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1093\/oxfordjournals.aje.a117548","volume":"142","author":"NJ Talley","year":"1995","unstructured":"Talley NJ, Zinsmeister AR, Melton LJ: Irritable bowel syndrome in a community: symptom subgroups, risk factors, and health care utilization. Am J Epidemiol 1995, 142: 76\u201383.","journal-title":"Am J Epidemiol"}],"container-title":["Current Treatment Options in Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11938-004-0017-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11938-004-0017-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11938-004-0017-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T17:51:20Z","timestamp":1587577880000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11938-004-0017-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,8]]},"references-count":74,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,8]]}},"alternative-id":["17"],"URL":"https:\/\/doi.org\/10.1007\/s11938-004-0017-1","relation":{},"ISSN":["1092-8472","1534-309X"],"issn-type":[{"value":"1092-8472","type":"print"},{"value":"1534-309X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,8]]}}}